A Single and Multiple Ascending Dose Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD2389 in Healthy Participants
Clinical trial NCT06138795 · COMPLETED
Trial details
- NCT number
- NCT06138795
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-20
- Primary completion
- 2025-08-24
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.